12:00 AM
Mar 26, 2012
 |  BC Week In Review  |  Company News  |  Deals

Altacor, Nicox deal

NicOx will acquire an 11.8% stake in ophthalmic company Altacor for £2 million ($3.2 million) in cash. NicOx also received an exclusive option to acquire the remaining Altacor shares for an additional £9 million ($14.2 million) in cash and/or stock. The option expires May 31....

Read the full 205 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >